- Home
- EXAI
EXAI
Exscientia Plc
as 11-07-2024 4:00pm EST
Exscientia PLC is engaged in the application of artificial intelligence (AI) and machine learning (ML) to the discovery and design of novel therapeutic compounds. The company's technology platform combines human and computational capabilities to accelerate the process of designing novel, safe, and efficacious compounds for clinical testing in humans. The company is focused on the discovery and development of small-molecule drug candidates.
| Founded: | 2012 | Country: | United Kingdom |
| Employees: | N/A | City: | N/A |
| Market Cap: | 635.8M | IPO Year: | 2021 |
| Target Price: | $7.00 | AVG Volume (30 days): | 485.2K |
| Analyst Decision: | Hold | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.30 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.80 - $7.91 | Next Earning Date: | 11-15-2024 |
| Revenue: | $26,566,153 | Revenue Growth: | -3.92% |
| Revenue Growth (this year): | 156.33% | Revenue Growth (next year): | -28.30% |
Latest Exscientia Plc News
EXAI Breaking Stock News: Dive into EXAI Ticker-Specific Updates for Smart Investing
TipRanks
22 days ago
Exscientia advances two additional discovery programs with Sanofi
MT Newswires
23 days ago
Exscientia Expects $15 Million in Milestone Payments From Sanofi
Business Wire
23 days ago
Exscientia Achieves Milestones for Two Programmes in Sanofi Collaboration
Insider Monkey
a month ago
Recursion’s All-Stock Acquisition of Exscientia plc (EXAI): NVIDIA-Backed Merger to Revolutionize AI-Driven Drug Discovery
TipRanks
a month ago
Exscientia Set for Strategic Acquisition by Recursion
Business Wire
a month ago
Exscientia to Present New Preclinical Data for AI-designed LSD1 and MALT1 Inhibitors at ENA 2024
Zacks
a month ago
Harrow (HROW) Surges 8.4%: Is This an Indication of Further Gains?
Pharmaceutical Technology
a month ago
Exscientia outline robot and AI use in drug discovery workflow
Compare EXAI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "EXAI Exscientia Plc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.